India
· Delayed Price · Currency is INR Nectar Lifesciences Statistics
Total Valuation
NSE:NECLIFE has a market cap or net worth of INR 8.02 billion. The enterprise value is 14.12 billion.
| Market Cap | 8.02B |
| Enterprise Value | 14.12B |
Important Dates
The next estimated earnings date is Tuesday, February 11, 2025.
| Earnings Date | Feb 11, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
NSE:NECLIFE has 224.26 million shares outstanding. The number of shares has increased by 3.12% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 224.26M |
| Shares Change (YoY) | +3.12% |
| Shares Change (QoQ) | +0.02% |
| Owned by Insiders (%) | 46.60% |
| Owned by Institutions (%) | 0.04% |
| Float | 117.46M |
Valuation Ratios
The trailing PE ratio is 48.08.
| PE Ratio | 48.08 |
| Forward PE | n/a |
| PS Ratio | 0.48 |
| PB Ratio | 0.74 |
| P/TBV Ratio | 0.78 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 83.07 |
| EV / Sales | 0.84 |
| EV / EBITDA | 7.96 |
| EV / EBIT | 12.23 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.58 |
| Debt / EBITDA | 3.55 |
| Debt / FCF | n/a |
| Interest Coverage | 1.38 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 4.18% |
| Return on Capital Employed (ROCE) | n/a |
| Revenue Per Employee | 9.97M |
| Profits Per Employee | 100,835 |
| Employee Count | 1,686 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -1.49% in the last 52 weeks. The beta is 1.13, so NSE:NECLIFE's price volatility has been higher than the market average.
| Beta (5Y) | 1.13 |
| 52-Week Price Change | -1.49% |
| 50-Day Moving Average | 37.91 |
| 200-Day Moving Average | 36.06 |
| Relative Strength Index (RSI) | 40.33 |
| Average Volume (20 Days) | 778,036 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, NSE:NECLIFE had revenue of INR 16.81 billion and earned 170.01 million in profits. Earnings per share was 0.74.
| Revenue | 16.81B |
| Gross Profit | 5.08B |
| Operating Income | 1.15B |
| Pretax Income | 372.44M |
| Net Income | 170.01M |
| EBITDA | 1.77B |
| EBIT | 1.15B |
| Earnings Per Share (EPS) | 0.74 |
Balance Sheet
The company has 187.35 million in cash and 6.29 billion in debt, giving a net cash position of -6.10 billion or -27.22 per share.
| Cash & Cash Equivalents | 187.35M |
| Total Debt | 6.29B |
| Net Cash | -6.10B |
| Net Cash Per Share | -27.22 |
| Equity (Book Value) | 10.78B |
| Book Value Per Share | 48.13 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 30.22%, with operating and profit margins of 6.87% and 1.01%.
| Gross Margin | 30.22% |
| Operating Margin | 6.87% |
| Pretax Margin | 2.22% |
| Profit Margin | 1.01% |
| EBITDA Margin | 10.55% |
| EBIT Margin | 6.87% |
| FCF Margin | n/a |
Dividends & Yields
NSE:NECLIFE does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -3.12% |
| Shareholder Yield | -3.12% |
| Earnings Yield | 2.12% |
| FCF Yield | n/a |
Stock Splits
The last stock split was on November 12, 2008. It was a forward split with a ratio of 10.
| Last Split Date | Nov 12, 2008 |
| Split Type | Forward |
| Split Ratio | 10 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |